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Abstract
This study investigates the effects of replacing dietary casein by soya protein on the underlying mechanisms involved in the impaired
metabolic fate of glucose and lipid metabolisms in the heart of dyslipidaemic rats chronically fed (8 months) a sucrose-rich (62·5%) diet (SRD).
To test this hypothesis, Wistar rats were fed an SRD for 4 months. From months 4 to 8, half the animals continued with the SRD and the other
half were fed an SRD in which casein was substituted by soya. The control group received a diet with maize starch as the carbohydrate source.
Compared with the SRD-fed group, the following results were obtained. First, soya protein significantly (P< 0·001) reduced the plasma NEFA
levels and normalised dyslipidaemia and glucose homoeostasis, improving insulin resistance. The protein levels of fatty acid translocase at
basal state and under insulin stimulation and the protein levels and activity of muscle-type carnitine palmitoyltransferase 1 were normalised.
Second, a significant (P< 0·001) reduction of TAG, long-chain acyl CoA and diacylglycerol levels was observed in the heart muscle. Third,
soya protein significantly increased (P< 0·01) GLUT4 protein level under insulin stimulation and normalised glucose phosphorylation and
oxidation. A reduction of phosphorylated AMP protein kinase protein level was recorded without changes in uncoupling protein 2 and PPARα.
Fourth, hydroxyproline concentration decreased in the left ventricle and hypertension was normalised. The new information provided shows
the beneficial effects of soya protein upon the altered pathways of glucose and lipid metabolism in the heart muscle of this rat model.
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Changes in lifestyle (increase in the consumption of diets high
in saturated fat and/or refined sugars), physical activities and
genetic factors play an important role in the development
of metabolic disorders including the so-called metabolic
syndrome (MS)(1). This syndrome increases the risk of type 2
diabetes and CVD(2). The latter is considered the leading cause
of death in Western countries and the world(3). As diet plays
a key role in these metabolic alterations, there has been
an increase in research focused on nutritional and dietary
interventions to prevent or improve CVD.
Among other nutrients, soyabean has been widely studied
because it contains vegetable proteins of high biological value, bio-
active peptides, PUFA, dietary fibre and phytochemicals (e.g. iso-
flavones and phytate), which may contribute to the reduction of the
risk factors of CVD, type 2 diabetes and atherosclerosis(4,5). The
antioxidant action of isoflavones helps to reduce lipid peroxidation,
and the increased HDL-cholesterol levels act as a protective factor
against possible cardiovascular events(6). Studies in different
rodent models of obesity showed that soya protein reduces
dyslipidaemia and lipotoxicity in the liver through mechanisms
that include reduction of fatty acid (FA) synthesis and increased
FA oxidation(7,8), among others. On the other hand, myocardial
lipotoxicity (increased TAG, diacylglycerol and ceramide con-
tents) is known to be a contributing factor in the development of
diabetic cardiomyopathy(9). In this regard, Torre-Villalvazo
et al.(10) demonstrated that dietary soya protein prevents
lipotoxicity in the heart of rats with diet-induced obesity and in
ob/ob mice. In male spontaneous hypertensive rats (SHR), the
administration of isolate soya protein decreases systolic blood
pressure(11). Besides, a long-term consumption of soya protein in
rats fed a high-fat diet significantly decreased serum glucose and
insulin/glucagon ratio and prevented insulin resistance(12).
Mizushige et al.(13) showed that genistein, one of the main soya
isoflavones, suppressed the progression of myocardial fibrosis in
Long-Evans Tokushima Otsuka (LETO) rats.
On the other hand, rats chronically fed a sucrose-rich diet (SRD)
developed a stable model of dyslipidaemia, insulin resistance,
hypertension and visceral adiposity, which mimicked several
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metabolic abnormalities of the MS in humans(14–17). Moreover, the
heart of these rats displayed deep alterations of myocardial substrate
utilisation leading to increased FA uptake, impaired glucose meta-
bolism and lipotoxicity(18–21). Along this line, we recently demon-
strated that the addition of dietary soya protein instead of casein
normalised dyslipidaemia, glucose homoeostasis and adipose tissue
dysfunction and improved whole-body insulin sensitivity in rats
chronically fed a SRD(22–24). However, to the best of our knowl-
edge, the possible beneficial effects of dietary soya protein on the
mechanisms involved in the altered lipid and glucose metabolism in
the heart of these rats have not been investigated. Therefore, we
considered that it was worthwhile to explore whether soya protein
could improve or even revert the mechanisms underlying the
impaired metabolic fate of glucose and lipid metabolism in the heart
muscle of a dyslipidaemic, insulin-resistant rat model fed an SRD. In
an attempt to answer this question, the present study was designed
to evaluate the following aspects in the heart muscle: (a) meta-
bolites and key enzymes activities involved in both the metabolic
fate of glucose and the excessive bio-active lipid accretion; (b) the
protein levels of fatty acid translocase (FAT/CD36) and GLUT4 at
basal conditions and under insulin stimulation; and (c) the protein
levels of PPARα, the mitochondrial uncoupling protein 2 (UCP2)
involved in the control of heart muscle bioenergetics and total and
phosphorylated AMP-activated protein kinase (AMPK) – a meta-
bolic sensor of cellular energy status. Besides, the hydroxyproline
content of the left ventricle was analysed as an estimation of
collagen deposition. In addition, blood pressure and plasma lipid
levels were measured. This study was conducted in rats fed an SRD
for 8 months in which the metabolic abnormalities mentioned
above were present before casein was replaced by soya as a dietary
protein source for the last 4 months of the experimental period in
half of the animals.
Methods
Animals
Male Wistar rats initially weighing 170–185 g purchased from
the National Institute of Pharmacology were maintained with
unrestricted access to water and food under controlled
temperature (22± 1°C), humidity and airflow condition, with a
fixed 12 h light–12 h dark cycle (lights on from 07.00 to
19.00 hours). Adequate measures were taken to minimise the
pain or discomfort of the rats and we used the smallest possible
number of animals. The animal protocol was approved by
the Human and Animal Research Committee of the School
of Biochemistry, University of Litoral, Santa Fe, Argentina
(FONCYT–PICT no. 945/2012).
Experimental design
The rats were initially fed a standard non-purified diet (Ralston).
After 1 week of acclimatisation period, the rats (n 72) were
randomly divided into two groups (control and experimental)
and were housed individually. The experimental group received
a purified SRD (n 48) containing by weight 62·5 (g/100 g) sucrose
and the control group received the same purified diet but with
sucrose replaced by maize starch (control diet (CD)) (n 24).
Details on the composition of the diets are given in Table 1. Both
groups received each diet for 4 months. At that time, rats in the
SRD group were randomly subdivided into two subgroups. The
first subgroup (n 24) continued on the SRD up to 8 months of
feeding and the second subgroup (n 24, SRD-S) received the SRD
in which the source of protein casein was replaced by soya
protein isolate (MP Biomedicals) for the next 4 months. The
control group was fed the CD throughout the experimental
period. All diets provided approximately 16·30 kJ/g of food and
were available ad libitum. Diets were prepared every week.
The preparation and handling of diets have been reported
elsewhere(23,24). The weight of each animal and the energy
intake were recorded twice per week throughout the experi-
mental period in all groups and subgroups of rats. At the end of
the experimental period, food was removed at 07.00 hours (end
of the dark period), and unless otherwise indicated experiments
were performed under feed conditions.
Analytical methods
Blood pressure was measured in the three dietary groups in
conscious animals during the experimental period using CODA
Table 1. Composition of the experimental diets (based on the modified American Institute of Nutrition (AIN)-93 diet)
CD SRD SRD-S*
Diet ingredients g/100 g % Energy g/100 g % Energy g/100 g % Energy
Maize starch 62·5 65 – – – –
Sucrose – – 62·5 65 62·5 65
Casein-free vitamin 18 19 18 19 – –
Soya protein – – – – 18 19
Maize oil 7 16 7 16 7 16
Vitamin mix† 1 1 1
Cellulose 7·5 7·5 7·5
Salt mix‡ 3·5 3·5 3·5
Choline bitartrate 0·2 0·2 0·2
DL-Methionine 0·3 0·3 0·3
CD, control diet, SRD, sucrose-rich diet; SRD-S, SRD with soya protein.
* Soya protein isolated (MP Biomedicals). Soya protein isolate composition (g/100g): protein, 92·0; water, 6·0; ash, 4·1; fat, 0·8; fibre, 0·25; carbohydrate,
2·85; Ca, 0·15; P, 0·8; K, 0·05; Na, 1·3; isoflavone, 0·0175; total trypsin inhibitor protein, 4·0–7·3mg/g.
† AIN-93 VX.
‡ AIN-93M MX.
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TM Monitor of tail-cuff non-invasive blood pressure system
(Kent Scientific Corporation), as previously described(18).
Rats from the three dietary groups were anaesthetised with
intraperitoneal sodium pentobarbital (60mg/kg body weight).
Blood samples were obtained from the jugular vein. Plasma
TAG, NEFA, total and HDL-cholesterol, glucose and immuno-
reactive insulin levels were determined as previously descri-
bed(15). The heart muscle was totally removed; then, it was
weighed and at least in six animals at random in each dietary
group the left ventricle was separated and weighed. The heart
tissue was stored at the temperature of liquid N2. In
the homogenate of frozen heart muscle, the levels of TAG, long-
chain acyl CoA (LC ACoA), diacylglycerol (DAG), glycogen and
glucose-6-phosphate content were determined as described
by D’Alessandro et al.(21). Hexokinase (HK), pyruvate
dehydrogenase complex (PDHc) and muscle-type carnitine
palmitoyl transferase 1 (M-CPT1) and CPT2 activities were
analysed as recently described by Creus et al.(18).
Determination of hydroxyproline content in the
left ventricle
Hydroxyproline content was analysed according to the procedure
reported by Neuman & Logan(25) with slight modifications.
In brief, the myocardial tissue from the left ventricle was hydro-
lysed with 6M-HCl at 120°C for 24h. Hydroxyproline content in
the resultant hydrolysate was determined by oxidation with 6%
(v/v) H2O2, followed by a colorimetric reaction with 5% (w/v)
p-dimethylaminobenzaldehyde. The intensity of red product
was measured at 540nm. The amount of hydroxyproline in
the unknown sample was calculated using a standard curve of
hydroxyproline.
Determination of fatty acid translocase and GLUT4 protein
levels during euglycaemic–hyperinsulinaemic clamp studies
and protein levels of muscle-type carnitine palmitoyl
transferase 1, PPARα, uncoupling protein 2, total and
phosphorylated (Thr 172) AMP-activated protein kinase
at basal conditions
After 5 h of food deprivation, the heart muscle of six rats from
the CD, SRD and SRD-S groups were rapidly removed (time 0
of clamp study) and stored at −80°C for the determination of
FAT/CD36(18) and GLUT4(22) protein levels. Immediately, in the
other six rats from each dietary group, an infusion of highly
purified porcine neutral insulin (Actrapid; Novo Nordisk) was
administered at 0·8 units/(kg× h) for 120min. Glycaemia was
maintained at a euglycaemic level by infusing glucose at a
variable rate. The glucose infusion rate (GIR) during the second
hour of the clamp study was taken as the net steady state of the
whole-body glucose as previously described(17). At the end of
the clamp period, the heart muscle of each dietary group was
rapidly removed for the determination of the FAT/CD36 and
GLUT4 protein levels. Plasma membrane fractions from heart
muscle were prepared as previously described(18). Frozen heart
powder homogenate from another six rats of each dietary group
was used for the basal determination of M-CPT1, PPARα, AMPK
and phosphorylated AMP-activated protein kinase (pAMPK)
(Thr172) protein levels, whereas in the mitochondrial fraction
UCP2 protein level was assessed as previously described by
Creus et al.(18,20). Protein concentrations were quantified by the
Bradford assay (Bio-Rad reagent), separated by SDS-PAGE and
transferred to PVDF membranes. Each gel contained an equal
number of samples from rats fed a CD, SRD and SRD-S at the
beginning (0min) and at the end (120min) of the euglycaemic–
hyperinsulinaemic clamp for the determinations of FAT/CD36
and GLUT4 and at basal conditions for M-CPT1, PPARα, AMPK,
pAMPK (Thr172) and UCP2. The membranes were probed
with specific antibodies: rabbit polyclonal anti-FAT/CD36, anti-
M-CPT1, anti-PPARα and anti-AMPK or anti-pAMPK (Thr172),
goat polyclonal anti-GLUT4 and anti-UCP2, all of them from
Santa Cruz Biotechnology, Inc. The blots were incubated with
horseradish-peroxidase-linked secondary antibody (Santa Cruz
Biotechnology) followed by chemiluminescence detection
according to the manufacturer’s instructions (Pierce Bio-
technology). β-Actin was used as a loading control. The inten-
sity of the bands was quantified using the National Institute of
Health imaging software. After the densitometry of immuno-
blots, the GLUT4 and the FAT/CD36 of the CD groups at the
beginning of the clamp were normalised to 100%, and both the
SRD and SRD-S groups at the beginning and the three dietary
groups at the end of the study were expressed relative to this,
whereas the densitometry of immunoblots, from M-CPT1,
PPARα, UCP2, AMPK and pAMPK, from each CD group was
normalised to 100%, and the SRD and SRD-S groups were
expressed relative to this.
Preliminary studies showed linearity of Western blot assays
from both GLUT4 and FAT/CD36 from 25 to 100μg of proteins;
from 50 to 150 μg of proteins for M-CPT1 and PPARα; and
25–100μg of proteins for UCP2, AMPK and pAMPK. The cor-
relation coefficient between the amount of protein and the
enhanced chemiluminescence image intensity was 0·97 for
FAT/CD36, M-CPT1, UCP2 and AMPK fractions and 0·98 for
GLUT4, PPARα and pAMPK fractions. All of them had P< 0·01.
The relationship between the amount of the sample subjected to
immunoblotting and the signal intensity observed was linear
under the conditions described above.
Statistical analysis
Sample sizes were calculated on the basis of measurements
previously made with rats fed either a CD or an SRD(18,21,23)
considering an 80% power(26). Results were expressed as
mean values with their standard errors. Statistical comparisons
were made transversely between different dietary groups. The
normal distribution of data was tested using Shapiro–Wilk’s test.
The homogeneity of variances was tested using Levene’s test.
The statistical significance between groups was determined
by one-way ANOVA, with one factor (diet) followed by the
Newman–Keuls multiple comparison post hoc test(27). When
appropriate, the statistical significance between the two groups
(CD and SRD) was determined by Student’s t test. Differences
having P values lower than 0·05 were considered to be
statistically significant (SPSS 15.0 for Windows; SPSS Inc.).
All reported P values are two-sided.
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Results
Body weight, energy intake, total and relative heart and left
ventricle weight, plasma metabolite and insulin levels and
glucose infusion rate
As previously demonstrated(22,24) and confirmed in the
present work, the increased body weight gain and energy intake
recorded in rats fed an SRD were normalised by the adminis-
tration of soya protein. Both total heart and left ventricle weight
significantly increased in SRD-fed rats at the end of the experi-
mental period. However, both parameters expressed relative to
100g of body weight were similar to those observed in the CD
group. The present study shows that total heart and left ventricle
weight were similar to those recorded in the CD group after the
administration of soya protein. Dietary soya normalised plasma
metabolites without changes in insulin levels (Table 2). Besides,
the altered GIR value previously observed in the rats fed an
SRD was improved in the SRD-S-fed rats. Mean values were as
follows: (six animals per group); CD 11·5 (SEM 0·8)mg/
(kg×min), SRD 4·4 (SEM 0·6)mg/(kg×min), SRD-S 8·6
(SEM 0·7)mg/(kg×min) (P< 0·001 SRD v. CD and SRD-S; P< 0·05
CD v. SRD-S).
Blood pressure, heart rate and heart muscle hydroxyproline
levels
Fig. 1 shows the time course of systolic and diastolic blood
pressure, as well as heart rate, throughout the experimental
period in the three dietary groups. From month 1 until the end,
the animals fed the SRD showed a significant increase in systolic
and diastolic blood pressure compared with the CD-fed group.
Similarly, the heart rate of SRD-fed rats significantly increased
from month 3 until the end. Soya protein administration in the
SRD group (SRD-S) was able to decrease the systolic and dia-
stolic blood pressure after 2 months of ingestion, reaching
values similar to those of the control group. A significant
decrease of heart rate was just recorded after 1 month of soya
protein administration and continued until the end of the
experimental period.
Besides, a significant increase of hydroxyproline contents –
as a proportional estimation of myocardial collagen content(28)
– was recorded in the heart of the SRD-fed group after 4 months
on the diet. Mean values were as follows: (six animals
per group); CD 459·2 (SEM 23·0) µg/g wet tissue, SRD 595·7
(SEM 27·0) µg/g wet tissue (P< 0·01 SRD v. CD). At the end of
the experimental period, the hydroxyproline content was
normalised when soya protein replaced casein in the SRD
group, reaching values similar to those observed in the control
group. Mean values were as follows: (six animals per group);
CD 469·8 (SEM 20·0) µg/g wet tissue, SRD 605·7 (SEM 28·5) µg/g
wet tissue and SRD-S 520·6 (SEM 25·5) µg/g wet tissue (P< 0·01
SRD v. CD; P< 0·05 SRD v. SRD-S).
Heart muscle metabolite concentration and enzyme
activities
Table 3 shows in the heart muscle of SRD-fed rats a significant
decrease of glucose-6-phosphate and glycogen content with a
significant increase of lipid storage (TAG, LC ACoA and DAG), in
agreement with a previous study(21). This was accompanied by a
reduction of HK and PDHa – the active form of the PDHc –
activities. The present data show that dietary soya protein was
able to normalise these parameters, reaching values similar to
those recorded in the CD-fed group. Moreover, the activity of
M-CPT1 significantly decreased (P< 0·001), reaching values
similar to those observed in the control group when soya protein
Table 2. Body weight, energy intake, total and relative heart and left ventricle weights, plasma metabolite and insulin levels in rats fed a control diet (CD), a
sucrose-rich diet (SRD) or an SRD with soya protein (SRD-S)†
(Mean values with their standard errors; n 6)
CD SRD SRD-S
Mean SEM Mean SEM Mean SEM
Body weight (g)
Initial 185·2 2·4 186·2 3·2
4 months 408·2 5·5 414·3 6·2
Final (8 months) 487·0 6·4 518·3* 5·4 492·0 9·7
Energy intake (kJ/d)
Initial to 4 months 263·8 6·5 266·9 4·5
4–8 months 280·8 12·1 362·3*** 9·8 279·5 8·9
Heart tissue
Total weight (g) 1·228 0·008 1·328*** 0·021 1·226 0·046
Relative weight (g/100 g BW) 0·261 0·008 0·252 0·004 0·247 0·007
Left ventricle weight (g) 0·888 0·013 0·962* 0·017 0·905 0·008
Relative left ventricle (g/100 g BW) 0·191 0·006 0·183 0·002 0·181 0·006
Plasma
Glucose (mM) 6·4 0·2 8·3** 0·4 6·8 0·3
Insulin (pM) 395·0 30·3 413·8 29·4 398·0 22·1
TAG (mM) 0·68 0·06 1·78*** 0·12 0·70 0·05
NEFA (μM) 316·0 22·5 713·0*** 21·8 321·0 20·5
Total cholesterol (mM) 2·20 0·06 3·21* 0·12 2·15 0·09
HDL-cholesterol (mM) 1·37 0·06 1·30 0·06 1·43 0·05
Mean values were significantly different from those of the CD and SRD-S: * P<0·05, ** P<0·01, ***P< 0·001.
† For details of procedures and diets, see the ‘Methods’ section and Table 1.
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replaced casein in the SRD group, whereas CPT2 activity
remained similar in all dietary groups (data not shown).
Muscle-type carnitine palmitoyl transferase 1, PPARα and
uncoupling protein 2 protein levels
The immunoblotting of the heart muscle revealed a single 75-
kDa band consistent with M-CPT1; a 55-kDa band consistent
with PPARα; and a 33-kDa band consistent with UCP2
(Fig. 2(a)–(c), top panel). The relative abundance of M-CPT1
protein level that was significantly increased (P< 0·001) in the
heart of SRD-fed rats decreased in the SRD-S group, reaching
values similar to the CD group (Fig. 2(a), bottom panel).
Besides, the relative abundance of PPARα that was significantly
increased (P< 0·01) in the heart of SRD-fed rats was still higher
after soya protein administration (Fig. 2(b), bottom panel).
Further, no changes in the protein levels of UCP2 in the three
dietary groups were observed (Fig. 2(c), bottom panel).
Table 3. Metabolite and enzyme activities in heart muscle in rats fed a control diet (CD), a sucrose-rich diet (SRD) or an SRD with soya protein (SRD-S) at
the end of experimental period†
(Mean values with their standard errors; n 6)
CD SRD SRD-S
Mean SEM Mean SEM Mean SEM
Metabolites
Glucose-6-phosphate (µmol/g wet tissue) 0·78 0·10 0·48* 0·06 0·66 0·05
Glycogen (µmol/g wet tissue) 16·3 0·8 12·2** 0·5 15·1 0·6
TAG (µmol/g wet tissue) 3·71 0·20 5·93*** 0·30 3·84 0·17
LC ACoA (nmol/g wet tissue) 35·1 4·5 67·2*** 3·8 45·2 2·5
DAG (nmol/g wet tissue) 253·8 18·2 357·2*** 16·1 260·4 14·6
Enzyme activities
HK (mU/mg protein) 65·6 0·8 39·2*** 1·2 65·2 0·9
PDHa (% of total PDHc) 62·1 5·5 34·4*** 4·2 53·1 2·3
M-CPT1 (mU/mg protein) 8·70 0·78 22·35*** 2·10 10·45 1·10
DAG, diacylglycerol; LC ACoA, long-chain acyl CoA; HK, hexokinase; PDHc, pyruvate dehydrogenase complex; M-CPT1, muscle-type carnitine palmitoyltransferase 1.
Mean values were significantly different from those of the CD and SRD-S groups: * P<0·05, ** P<0·01, *** P<0·001.
† For details of procedures and diets, see the ‘Methods’ section and Table 1.
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Fig. 1. Time course of systolic and diastolic blood pressure and heart rate throughout the experimental period in rats fed a control diet (CD, ), a sucrose-rich diet
(SRD, ) or an SRD with soya protein (SRD-S, ). Values are means (six animals per group), with their standard errors represented by vertical bars. Systolic and
diastolic blood pressure: mean values were significantly different – *CD v. SRD rats; † SRD v. SRD-S rats (P<0·05) at each time point. Heart rate: mean values were
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GLUT4 protein level at the beginning and at the end of
the euglycaemic–hyperinsulinaemic clamp studies
The immunoblotting of lysate heart tissue revealed a single
45-kDa band consistent with GLUT4 (Fig. 3, top panel). At the
beginning of the clamp, no differences were observed in the
relative abundance of the total plasma membrane of GLUT4
protein between all groups. Under insulin stimulation, the
translocation of GLUT4 to the plasma membrane significantly
increased in the CD-fed rats, whereas the increase was very low
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Fig. 2. Heart protein levels of muscle-type carnitine palmitoyl transferase 1 (M-CPT1), PPARα and uncoupling protein 2 (UCP2) in rats fed a control diet (CD), a
sucrose-rich diet (SRD) or an SRD with soya protein (SRD-S). (a): Top panel: a representative immunoblot of M-CPT1 of heart muscle from CD, SRD or SRD-S.
Molecular marker is shown on the right. Lane 1, CD; lane 2, SRD; lane 3, SRD-S. Bottom panel: densitometric immunoblot analysis of M-CPT1 of heart muscle from
CD, SRD or SRD-S. (b) Top panel: a representative immunoblot of PPARα of heart muscle from CD, SRD or SRD-S. Molecular marker is shown on the right. Lane 1,
CD; lane 2, SRD; lane 3, SRD-S. Bottom panel: densitometric immunoblot analysis of PPARα of heart muscle from CD, SRD or SRD-S. (c) Top panel: a representative
immunoblot of UCP2 of heart muscle from CD, SRD or SRD-S. Molecular marker is shown on the right. Lane 1, CD; lane 2, SRD; lane 3, SRD-S. Bottom panel:
densitometric immunoblot analysis of UCP2 of heart muscle from CD, SRD or SRD-S. Values are means (six animals per group), with their standard errors represented
by vertical bars and expressed as percentage relative to the CD. (a) *** (P< 0·001) SRD v. CD and SRD-S; (b) ** (P< 0·01) SRD and SRD-S v. CD.
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in the SRD-fed group. When soya replaced casein in the
SRD-fed rats, the GLUT4 protein level significantly increased
(45%), although values were still lower than those recorded in
the control group (Fig. 3, bottom panel).
Fatty acid translocase protein level in heart muscle at
the beginning and at the end of the euglycaemic–
hyperinsulinaemic clamp studies
The immunoblotting of the heart muscle revealed a single
90-kDa band consistent with FAT/CD36 (Fig. 4, top panel).
Similar to our previous report(18), at the beginning of the clamp,
a significant increase of the relative abundance of FAT/CD36 in
the SRD-fed rats was reached compared with both the CD
and SRD-S groups. After insulin stimulation, a significant
increase of FAT/CD36 to the sarcolemma was observed in both
the CD and SRD-S groups. However, insulin was unable to
further recruit FAT/CD36 to the sarcolemma in the SRD-fed
rats under the same experimental conditions (Fig. 4, bottom
panel).
Total and phosphorylated (Thr 172) AMP-activated protein
kinase protein level
The immunoblotting of lysate heart tissue revealed a single
63-kDa band consistent with the AMPK and pAMPK (Fig. 5(a)
and (b), top panel). The relative abundance of AMPK protein
level was similar in the three dietary groups, whereas pAMPK
significantly increased (P< 0·001) in the heart of the SRD-fed
group. When casein was replaced by soya protein as a dietary
protein (SRD-S), a significant reduction of pAMPK protein level
was observed. In this group, values returned to those recorded
in the CD-fed rats (Fig. 5(a) and (b), bottom panel). Besides, the
significant increase of the pAMPK/AMPK protein level ratio
observed in the SRD-fed rats was completely normalised in the
SRD-S group (Fig. 5c).
Discussion
The present study aimed to provide new information on the
beneficial effects of dietary soya protein on improving/
reversing the underlying mechanisms involved in the impaired
glucose metabolism and lipotoxicity induced in the heart of
dyslipidaemic, insulin-resistant rats by chronically feeding
them a SRD.
Long-chain FA and glucose are the major substrates with
which the heart sustains its mechanical performance. It has
been established that glucose uptake is the rate-limiting step in
glucose utilisation by muscle cells. Similarly, FA uptake is
governed by the FA gradient across the sarcolemma, whereas
the amount of sarcolemmal FAT/CD36 is a major determinant
of their uptake(29). Confirming a recent study(18), our data
show a deep alteration of myocardial substrate utilisation and
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Fig. 3. Heart muscle protein levels of GLUT4 at the beginning (0min) and
under the insulin stimulation at the end (120min) of the clamp studies in rats
fed a control diet (CD), a sucrose-rich diet (SRD) or an SRD with soya protein
(SRD-S). Top panel: a representative immunoblot of GLUT4 heart muscle from
CD, SRD or SRD-S. Molecular marker is shown on the right. Lane 1, CD 0min;
lane 2, CD 120min; lane 3, SRD 0min; lane 4, SRD 120min; lane 5, SRD-S
0min; lane 6, SRD-S 120min. Bottom panel: densitometric immunoblot
analysis of GLUT4 heart muscle from CD, SRD or SRD-S at the beginning
(0min,□) and at the end (120min,■) of clamp studies. Values are means (six
animals per group), with their standard errors represented by vertical bars and
expressed as percentage relative to the CD at 0min of the clamp. a,b Mean
values unlike letters were significantly different compared at the beginning and
the end of the clamp in each experimental group (P< 0·01). * Statistically
significant difference (P< 0·05) SRD-S v. CD rats at 120min of the clamp and
† (P< 0·01) SRD v. CD and SRD-S rats at 120min of the clamp.
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Fig. 4. Heart muscle protein levels of fatty acid translocase (FAT/CD36) at the
beginning (0min) and under the insulin stimulation at the end (120min) of the
clamp studies in rats fed a control diet (CD), a sucrose-rich diet (SRD) or an
SRD with soya protein (SRD-S). Top panel: a representative immunoblot of
heart FAT/CD36 of rats fed CD, SRD and SRD-S. Molecular marker is shown
on the right. Lane 1, CD 0min; lane 2, CD 120min; lane 3, SRD 0min; lane 4,
SRD 120min; lane 5, SRD-S 0min; lane 6, SRD-S 120min. Bottom panel:
densitometric immunoblot analysis of FAT/CD36 heart muscle from CD, SRD or
SRD-S at the beginning (0min, □) and at the end (120min, ■) of clamp
studies. Values are means (six animals per group), with their standard errors
represented by vertical bars and expressed as percentage relative to the CD at
0min of the clamp. a,b Mean values unlike letters were significantly different
compared at the beginning and the end of the clamp in each experimental
group (P< 0·01). * Statistically significant difference (P< 0·01) SRD v. CD and
SRD-S rats at 0min of the clamp.
Dietary soya protein and rat heart muscle 137
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451700321X
Downloaded from https://www.cambridge.org/core. Universidad Nac de Litoral, on 06 Apr 2018 at 19:43:52, subject to the Cambridge Core terms of use, available at
lipotoxicity in the heart of SRD-fed rats. An increase of protein
level of FAT/CD36 and impaired insulin-stimulated FAT/CD36
translocation to the plasma membrane were also observed. The
increase of plasma FA present in the SRD-fed group contributed
to enhance their uptake and oxidation due to Randle glucose-
FA cycle. Besides, transcriptional changes caused by the FA
induced the nuclear receptor PPARα activation(30). In this vein,
an increase in both the enzymatic activity and protein level of
M-CPT1 – a key site of control for the transport and oxidation
of FA into the mitochondria – was associated with an increase
of the protein level of PPARα. The present new data show that
when dietary soya protein replaced casein in the SRD group,
the protein level of plasma membrane FAT/CD36 at basal state
and the altered translocation under the stimulus of insulin
reached values similar to those recorded in the heart of rats fed
a CD. This suggests a reduced influx of FA into the heart of the
SRD-S-fed group. Besides, the administration of soya protein
was able to reverse both the increased protein level and activity
of M-CPT1, suggesting an amelioration of FA oxidation. This
was accompanied by a decrease in the availability of plasma FA,
owing to a significant decrease of the elevated basal lipolysis of
adipose tissue(16) and normalisation of dyslipidaemia in the
SRD-fed rats. This in turn led to a reduction of the intramyo-
cellular TAG contents and bio-active lipid deposition in the
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Fig. 5. (a) Heart protein levels of AMP-activated protein kinase (AMPK) and phosphorylated AMP-activated protein kinase (pAMPK) (Thr172) in rats fed a control diet
(CD), a sucrose-rich diet (SRD) or an SRD with soya protein (SRD-S). (a): Top panel: a representative immunoblot of AMPK of heart muscle from CD, SRD or SRD-S.
Molecular marker is shown on the right. Lane 1, CD; lane 2, SRD; lane 3, SRD-S. Bottom panel: densitometric immunoblot analysis of AMPK of heart muscle from CD,
SRD or SRD-S. (b): Top panel: a representative immunoblot of pAMPK (Thr172). Molecular marker is shown on the right. Lane 1, CD; lane 2, SRD; lane 3, SRD-S.
Bottom panel: densitometric immunoblot analysis of pAMPK of heart muscle from CD, SRD or SRD-S. Values are means (six animals per group), with their standard
errors represented by vertical bars and expressed as percentage relative to the control diet. *** (P< 0·001). (c) pAMPK:AMPK ratio in rats fed a CD, SRD or SRD-S.
Values are means (six animals per group), with their standard errors represented by vertical bars. *** (P< 0·001) SRD v. CD and SRD-S.
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cardiac muscle, improving their lipotoxicity. Further, the
nuclear receptor PPARα protein level was still higher in the
SRD-S group. This is an interesting finding considering that, as
mentioned above, the activity of M-CPT1, its target enzyme,
reached values similar to those of the CD-fed rats. Similarly,
Torres-Villalvazo et al.(10) showed in rats fed a high-fat diet and
in ob/ob mice that dietary soya protein reduced cardiac TAG
and cholesterol concentrations, as well as ceramide accumula-
tion associated with both a significant increase of mRNA PPARα
and a decrease of mRNA sterol regulatory element binding
protein 1c expression. In line with our results, soya protein
significantly decreased plasma NEFA, TAG and cholesterol
levels.
On the other hand, FA are also thought to play a role in the
activity of UCP. Li et al.(31) demonstrated that increased FA
induced UCP2 expression through PPARα activation in the adult
rat cardiomyocytes. An increase of myocardial UCP2 and UCP3
protein expression levels and a decrease of mitochondrial bio-
energetic function were also recorded in the heart of C57BL/6 J
mice with acute starvation(32). The heart of lean Zucker rats
showed a significant increase of UCP2 and UCP3 gene
expression during lipid infusion under an euglycaemic–hyper-
insulinaemic clamp(33). Further, Buchanan et al.(34) demon-
strated an increase of UCP2 and PPARα expression in the heart
of ob/ob mice. However, under the present experimental
conditions, our results showed no differences in the protein
level of UCP2, whereas values were similar in the three
dietary groups. At present, we are unaware of other studies that
evaluated the effect of a long-term administration of dietary
soya protein on the underlying mechanisms involved in the
altered lipid uptake and metabolism in the cardiac muscle of a
dyslipidaemic insulin-resistant rat model fed a high-sucrose diet.
Thus, the new finding collectively suggests that at least one of
the possible mechanisms that could contribute to normalise
the lipid fuel availability, the uptake and the accretion of
intramyocellular fat contents in the heart muscle of SRD-fed rats,
may involve the lipid-lowering effect of soya protein.
Insulin plays a key role in the regulation of substrate transport
and utilisation in the heart by stimulating both cardiac glucose
and FA uptake via GLUT4 and FAT/CD36 translocation,
respectively(35). On the other hand, heart muscle intramyocel-
lular FA accretion has been associated with insulin resistance as
they could interfere with the activation of insulin signalling
pathways involved in the recruitment of GLUT4 to the plasma
membrane. Impaired insulin-stimulated glucose uptake in the
heart has been described in animal models of diabetes, obesity
and hypertension(36). In this regard, and confirming previous
and recent studies(20,21), the hearts of SRD-fed rats display a
decline of insulin-stimulated cell surface recruitment of
GLUT4 protein level and altered the non-oxidative and
oxidative pathways of glucose metabolism. The present new
findings show that by shifting dietary casein to soya protein in
the SRD-fed group, the GLUT4 protein level significantly
increased under the stimulus of insulin. Besides, as mentioned
above, a normalisation of the altered transport of FAT/CD36
protein level, as well as lipotoxicity in the heart of the SRD-S
group, could favour the significant improvement of GLUT4
trafficking to the plasma membrane. In this vein, Bonen et al.(37)
demonstrated an inverse relationship between GLUT4
protein level expression and FA transport FAT/CD36 and lipid
accumulation in the heart muscle of lean ZDF rats.
The metabolic shift of lipid fate induced by dietary soya
protein also ameliorated the altered pathways of glucose
metabolism present in the heart of SRD-fed rats. Soya protein
was able to normalise glucose phosphorylation (the HK activity
reached values similar to those of the CD-fed rats), as well as
glucose-6-phosphate and glycogen concentration, within the
heart. Furthermore, the increase of PDHc activity recorded in
the SRD-S-fed rats suggests that the reduction of FA uptake and
oxidation could contribute to the normalisation of glucose
oxidation and the impaired balance of heart fuel utilisation.
Moreover, glucose homoeostasis and whole-body peripheral
insulin sensitivity were significantly improved after soya protein
administration. Interestingly, in the skeletal muscle of the same
experimental model, we recently demonstrated(22) that dietary
soya protein increased insulin-stimulated GLUT4 transporter,
reduced the accretion of intracellular lipids and normalised
glucose phosphorylation and oxidation, improving insulin
sensitivity and plasma glucose levels. In normal rats fed soya
protein, Lavigne et al.(38) observed an improvement of fasting
glucose tolerance and peripheral insulin sensitivity when
compared with rats fed casein.
On the other hand, AMPK – a metabolic monitor of cellular
status in the heart – plays a key role in muscle fuel preference
and flexibility. In the rat heart, insulin-induced stimulation of
PI3-kinase associated with IRS-1 is reduced by AMPK activa-
tion(39). In agreement with our previous study(20), an increase of
the pAMPK protein level and the pAMPK/AMPK ratio was
observed in the heart of SRD-fed rats. The present data show
that dietary soya protein was able to completely normalise both
parameters, which reached levels similar to those observed in
the CD-fed rats. Along this line, Konhilas et al.(40) recently
observed in the heart of sedentary male C57BL/6J mice fed a
casein-based diet an increase in the basal expression of
AMPKα2 – the most predominant isoform in the heart – com-
pared with mice fed a soya-protein-based diet. On the other
hand, Cederroth et al.(41) showed that soya diet containing high
phyto-oestrogen (genistein and daidzein the most predominant
ones) activated AMPK in white adipose tissue, skeletal muscle
and liver of male CD-1 mice. It was shown that genistein
and daidzein enhanced AMPK phosphorylation in the
gastrocnemius muscle of mice fed a high-fat-fructose diet and in
db/db mice, respectively(42,43). From the above studies, our
results might suggest that the low amount of phyto-oestrogens
present in the soya protein administered might contribute
to a lack of increase of AMPK phosphorylation in the heart of
SRD-S-fed rats. However, Samovski et al.(44) recently observed
in myocytes and other cell types that FAT/CD36 maintained
basal AMPK quiescence at low levels of FA. Moreover, an
increase of FA induced FAT/CD36 signalling activate AMPK,
which disinhibited β-oxidation recruiting more FAT/CD36 to the
sarcolemma. The hypolipidaemic effect of soya protein that
decreased plasma FA concentration and normalised both heart
FAT/CD36 protein level and FA oxidation may be another
mechanism involved in the behaviour of AMPK. Further studies
are needed to evaluate this issue.
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A number of studies have suggested that the consumption of
soya protein has favourable effects on obesity as it increases the
thermogenesis capacity of UCP1, decreases food intake and
increases satiety, reducing body fat and weight gain, among
others. In this regard, Oliva et al.(24) demonstrated that when
soya replaces casein in the SRD-fed rats during the last 4 months
of the feeding period, the amount of food intake, the body
weight gain and visceral adiposity are significantly lower than
those recorded in rats fed an SRD-casein. Under the same
experimental conditions, the present data confirmed these
results showing that food intake and body weight gain are
lower in SRD-S than those recorded in the age-matched rats fed
an SRD-casein. The present study does not analyse the
mechanism(s) underlying the effects of soya protein that leads
to a reduction of food intake in the SRD-fed rats. However,
Nishi et al.(45) showed in rats that soyabean β-conglycinin – the
main soyabean protein – reduces food intake and gastric
emptying by increasing cholecystokinin levels. Furthermore,
they also demonstrated that specific fragments of soya peptides
rich in arginine residues have strong food intake suppressor
activity. Besides, Banz et al.(46) reported that soya protein rich
in isoflavones reduces fat pad mass in Zucker diabetic fatty rats.
Thus, it is possible that the mechanisms mentioned above could
be involved in the decrease of food intake and body weight
gain when soya replaces casein in rats chronically fed an SRD.
This in turn might contribute to ameliorate whole-body insulin
resistance and dyslipidaemia.
In addition, in agreement with previous results, there was an
increase of blood pressure in the SRD-fed rats(18). This was
accompanied by a significant increase of left ventricle hydro-
xyproline concentration. The present data demonstrate that
the replacement of casein by soya protein normalised blood
pressure, decreasing heart rate and the levels of hydroxyproline in
the left ventricle of the SRD-S-fed group. A consistent body of
evidence from several human and experimental studies has shown
an inverse association between soya protein intake and blood
pressure. In this vein, Mahn et al.(47) suggested that consumption
of soya protein throughout life substantially reduced blood
pressure and improved endothelial function and antioxidant gene
expression in 12- to 16-month-old male rats. Yang et al.(48) showed
that a long-term administration of soyabean protein hydrolysate
might retard the development of hypertension in SHR by its
inhibitory effect on angiotensin-converting enzyme in vivo.
Furthermore, in these animals, a soya-based diet compared with
casein attenuates the development of hypertension(49). Moreover,
soya protein has high arginine and isoflavone contents, which
could contribute to their antihypertensive effects(50).
On the other hand, Mizushige et al.(13) observed that the
administration of genistein was able to decrease hydroxyproline
concentration in the heart muscle of LETO rats and significantly
suppressed the progression of myocardial fibrosis, although small
changes were recorded in OLETF rats. At present, we are not
aware of other studies analysing the mechanism/s by which dietary
soya protein normalises the blood pressure and the hydroxyproline
deposition in the cardiac muscle of SRD-fed rats; thus, we cannot
discard the possibility that the different components of the
soya protein isolate (e.g. antioxidant effects of isoflavones,
phyto-oestrogens, fibre) could be involved in these findings.
In brief, this study provides for the first time new information
on the beneficial effects of dietary soya protein to improve
some underlying key mechanisms collectively involved in the
altered pathways of glucose and lipid metabolism in the heart
muscle of a dyslipidaemic insulin-resistant rat model. This
nutritional manipulation was also effective in reducing left
ventricle hydroxyproline deposition and reversing hyperten-
sion. In this context, the normalisation of dyslipidaemia
and insulin resistance could protect the cardiac muscle to intra-
myocardial lipid deposition. However, whether these effects
are due exclusively to soya protein or also associated with
isoflavones or other micronutrients present in the protein
deserves further studies. Finally, although care must be taken
in extrapolating results from rats to humans, soya protein
consumption might be considered as a dietary therapeutic
approach for these metabolic diseases.
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